RIMBP2 and pancreatic adenocarcinoma: Notably, RIMBP2 expression was positively associated with pancreatic cancer patient survival in the TCGA PAAD cohort23 (Fig. 5f), indicating a potential protective function of both this noncoding mutation and RIMBP2.